Leelyn Smith, LLC Danaher Corp Transaction History

Leelyn Smith, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	SELL	$241.42 - $282.29 $25,349 - $29,640	-105 Reduced 63.64%	60 $15,000
Q3 2022 Nov 14, 2022	SELL	$247.06 - $1507.4 $105,000 - $640,645	-425 Reduced 72.03%	165 $43,000
Q2 2022 Aug 09, 2022	BUY	$237.11 - $299.66 $69,947 - $88,399	295 Added 100.0%	590 $150,000
Q2 2021 Aug 31, 2021	SELL	$225.08 - $271.69 $11,704 - $14,127	-52 Reduced 14.99%	295 $79,000
Q1 2021 May 05, 2021	SELL	$212.38 - $245.9 $48,847 - $56,557	-230 Reduced 39.86%	347 $78,000
Q4 2020 Jan 15, 2021	SELL	$212.5 - $245.46 $39,525 - $45,655	-186 Reduced 24.38%	577 $128,000
Q3 2020 Nov 05, 2020	SELL	$177.16 - $215.33 $16,830 - $20,456	-95 Reduced 11.07%	763 $164,000
Q2 2020 Aug 06, 2020	SELL	$128.7 - $176.83 $3,732 - $5,128	-29 Reduced 3.27%	858 $152,000
Q1 2020 May 06, 2020	BUY	$121.39 - $169.05 $107,672 - $149,947	887 New	887 $123,000

2,508

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $172B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Leelyn Smith, LLC, based on Form 13F filings with the SEC.

Stay updated on Leelyn Smith, LLC with notifications on news.